TheraRadar

Pharma Intelligence, Simplified

Pfizer

149 active trials across 15 therapeutic areas

149
Active Trials
57
Phase 1
45
Phase 2
60
Phase 3
15
Therapeutic Areas
Portfolio Concentration: 82% of active trials in Oncology

Oncology

122 active / 341 total
Solid Tumor (Advanced)
19 active 4 Ph3
60 total since 2015
Breast Cancer
16 active 4 Ph3
28 total since 2015
NSCLC
14 active 5 Ph3
40 total since 2015
Multiple Myeloma
9 active 4 Ph3
16 total since 2015
Prostate Cancer
8 active 5 Ph3
14 total since 2015
Melanoma
7 active 1 Ph3
18 total since 2015
Bladder Cancer
5 active 2 Ph3
17 total since 2015
ALL
5 active 1 Ph3
8 total since 2015
Colorectal Cancer
4 active
16 total since 2015
Head and Neck Cancer
4 active
15 total since 2015
Lung Cancer (General)
4 active 1 Ph3
9 total since 2015
SCLC
4 active 2 Ph3
4 total since 2015
Non-Hodgkin Lymphoma
3 active
10 total since 2015
Brain Tumor
3 active
5 total since 2015
Ovarian Cancer
2 active 1 Ph3
16 total since 2015
Pancreatic Cancer
2 active 1 Ph3
10 total since 2015
Sarcoma
2 active
7 total since 2015
Esophageal Cancer
2 active 1 Ph3
5 total since 2015
Thyroid Cancer
2 active
2 total since 2015
Renal Cell Carcinoma
1 active
6 total since 2015
Gastric Cancer
1 active 1 Ph3
4 total since 2015
Triple Negative Breast Cancer
1 active
3 total since 2015
Hepatocellular Carcinoma
1 active
2 total since 2015
Hodgkin Lymphoma
1 active
1 total since 2015
Cervical Cancer
1 active
1 total since 2015
HER2- Breast Cancer
1 active
1 total since 2015
Hematologic Malignancies
0 active
6 total since 2015
Squamous Cell Carcinoma
0 active
4 total since 2015
AML
0 active
4 total since 2015
Neuroendocrine Tumors
0 active
3 total since 2015
MDS
0 active
2 total since 2015
Cholangiocarcinoma
0 active
1 total since 2015
Endometrial Cancer
0 active
1 total since 2015
Mesothelioma
0 active
1 total since 2015
CML
0 active
1 total since 2015

Musculoskeletal

0 active / 5 total

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)